Arvinas, Inc. (ARVN) Social Stream



Arvinas, Inc. (ARVN): $34.72

0.43 (+1.25%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

ARVINAS INC (ARVN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ARVN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-06 13 $170 $101 $126.923 $42.33 199.84%
2022-01-18 14 $170 $101 $126.923 $42.33 199.84%
2022-02-08 14 $170 $97 $125.538 $42.33 196.57%
2022-02-14 15 $170 $97 $125.285 $42.33 195.97%
2022-02-22 15 $170 $91 $122.214 $42.33 188.72%
2022-03-09 15 $170 $91 $120.642 $42.33 185%
2022-03-22 15 $170 $91 $118.846 $42.33 180.76%
2022-04-01 15 $170 $91 $120.357 $42.33 184.33%
2022-04-08 16 $170 $65 $116.666 $42.33 175.61%
2022-04-28 16 $170 $65 $116.133 $42.33 174.35%
2022-05-06 16 $170 $65 $115.533 $42.33 172.93%
2022-05-08 16 $170 $64 $115.466 $42.33 172.78%
2022-05-09 16 $170 $43 $111.8 $42.33 164.12%
2022-05-23 16 $170 $43 $111.4 $42.33 163.17%
2022-05-24 16 $170 $43 $106.866 $42.33 152.46%
2022-06-21 17 $170 $42 $102.812 $42.33 142.88%
2022-07-27 16 $170 $42 $99.466 $42.33 134.98%
2022-08-05 16 $170 $42 $95.333 $42.33 125.21%
2022-08-09 16 $170 $42 $93.666 $42.33 121.28%
2022-08-13 15 $170 $42 $93.666 $42.33 121.28%
2022-08-18 15 $170 $42 $93.312 $42.33 120.44%
2022-09-05 15 $170 $42 $90.533 $42.33 113.87%
2022-09-17 15 $170 $42 $88.866 $42.33 109.94%
2022-10-19 16 $170 $42 $88.866 $42.33 109.94%
2022-11-08 17 $170 $42 $88.812 $42.33 109.81%
2022-11-14 17 $170 $42 $88.437 $42.33 108.92%
2022-11-22 17 $170 $42 $87.5 $42.33 106.71%
2022-11-23 17 $125 $42 $82.411 $42.33 94.69%
2022-12-05 18 $125 $42 $81.47 $42.33 92.46%
2022-12-20 18 $125 $42 $81.117 $42.33 91.63%
2023-01-03 18 $125 $42 $78.235 $42.33 84.82%
2023-01-10 18 $125 $42 $77.058 $42.33 82.04%
2023-01-12 19 $125 $27 $76.117 $42.33 79.82%
2023-02-08 18 $95 $27 $70.25 $42.33 65.96%
2023-02-24 18 $95 $27 $67.437 $42.33 59.31%
2023-04-25 18 $95 $30 $67.625 $42.33 59.76%
2023-05-08 18 $95 $30 $67.437 $42.33 59.31%
2023-05-10 18 $95 $27 $66.875 $42.33 57.98%
2023-05-11 18 $95 $27 $66.687 $42.33 57.54%
2023-06-09 17 $95 $27 $65.2 $42.33 54.03%
2023-07-26 16 $95 $27 $65.2 $42.33 54.03%
2023-08-09 16 $95 $27 $64.2 $42.33 51.67%
2023-09-15 16 $95 $27 $62.333 $42.33 47.25%
2023-10-24 16 $95 $24 $59.266 $42.33 40.01%
2023-10-25 16 $95 $24 $54.8 $42.33 29.46%
2023-11-08 16 $95 $24 $53.866 $42.33 27.25%
2023-11-13 16 $95 $20 $52.428 $42.33 23.86%
2023-11-20 16 $95 $20 $53.937 $42.33 27.42%
2023-12-06 18 $95 $20 $53.937 $42.33 27.42%
2023-12-08 18 $95 $20 $55.437 $42.33 30.96%
2023-12-19 18 $95 $20 $56.312 $42.33 33.03%

The Trend in the Analyst Price Target


Over the past 49 weeks, ARVN's average price target has gone down $19.22.

ARVN reports an average of 151.58% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-24 18 95 27 67.437 31.98 110.87%
2023-07-26 16 95 27 65.200 22.28 192.64%
2023-08-09 16 95 27 62.133 23.84 160.63%
2023-08-14 16 95 27 61.933 25.10 146.75%
2023-11-20 16 95 20 51.600 21.77 137.02%

ARVN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.11 17 0 1 0 0 18

The Trend in the Broker Recommendations


Over the past 31 weeks, ARVN's average broker recommendation rating improved by 0.34.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, ARVINAS INC's variance in analysts' estimates is lower than -5501.24% of them.
  • ARVINAS INC's number of analysts covering the stock is higher than 6074.7% of stocks in the mid market cap category.
  • ARVN has a higher average analyst price target than 5121.05% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, ARVINAS INC's upside potential (average analyst target price relative to current price) is greater than 4803.59% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ARVINAS INC are YMAB, ALLK, and AMRX.

Is ARVN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!